Categories
Change Password!
Reset Password!
Targeting the gut microbiome is emerging as a novel non-hormonal approach for alleviating menstrual pain in young women with primary dysmenorrhea.
Despite affecting a large proportion of reproductive-aged women, primary dysmenorrhea continues to be tackled predominantly with analgesics and hormonal therapies, leaving many patients seeking alternative treatment options. Increasing recognition of the gut–immune–neuroendocrine axis has prompted interest in whether microbial interventions could influence menstrual pain pathways. Researchers therefore investigated the therapeutic potential of multispecies probiotics in women experiencing moderate-to-severe menstrual pain.
A double-masked, placebo-controlled randomized trial enrolled young women diagnosed with clinically significant primary dysmenorrhea and monitored outcomes across multiple menstrual cycles. Participants received either daily probiotic supplementation or an inactive comparator, while changes in symptom burden were tracked using validated pain assessments during treatment and after therapy cessation to evaluate persistence of benefit.
The study demonstrated a clear divergence in pain trajectories between treatment groups over the intervention period. Women receiving probiotics experienced a substantially greater reduction in menstrual pain intensity, whereas symptom improvement in the placebo arm remained comparatively modest (Table 1).
Importantly, the therapeutic advantage diminished following discontinuation of supplementation, indicating that continued microbiome modulation may be prudent to sustain clinical benefit. The intervention displayed good tolerability, with no severe safety concerns identified throughout the study period.
The findings expanded the growing role of microbiome-based therapies in women's health and suggested that probiotic supplementation could complement existing treatment strategies for primary dysmenorrhea. Although the durability of benefit remains an important consideration, the study highlighted the potential for gut-directed therapies to redefine non-hormonal pain management approaches in menstrual health.
Scientific Reports
Efficacy of probiotic supplementation in reducing primary dysmenorrhea: a double-blinded randomized controlled trial
Orawin Vallibhakara et al.
Comments (0)